Skip to main content

Knuff & Co LLC

SEC CIK
0001768089
Latest filing
Aug 10, 2026

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by Knuff & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overviewAll 13F holders of VRTXFull Q2 2026 holdings

Shares (Q2 2026)
14,288
Value
$7.10M
% of portfolio
1.8%
Quarters held
22
Since Q1 2021
Holdings of VRTX by Knuff & Co LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202614,288$7.10M1.8%+307+2.2%AddedHolders
Q1 202613,981$6.24M1.9%−216−1.5%ReducedHolders
Q4 202514,197$6.44M1.9%+13+0.1%AddedHolders
Q3 202514,184$5.56M1.6%+188+1.3%AddedHolders
Q2 202513,996$6.23M2.0%+171+1.2%AddedHolders
Q1 202513,825$6.70M2.2%−116−0.8%ReducedHolders
Q4 202413,941$5.61M1.7%−252−1.8%ReducedHolders
Q3 202414,193$6.60M2.0%−150−1.0%ReducedHolders
Q2 202414,343$6.72M2.2%−70.0%ReducedHolders
Q1 202414,350$6.00M2.0%+169+1.2%AddedHolders
Q4 202314,181$5.77M2.1%−251−1.7%ReducedHolders
Q3 202314,432$5.02M2.0%−168−1.2%ReducedHolders
Q2 202314,600$5.14M1.9%−380−2.5%ReducedHolders
Q1 202314,980$4.72M1.9%−1,173−7.3%ReducedHolders
Q4 202216,153$4.66M2.0%−71−0.4%ReducedHolders
Q3 202216,224$4.70M2.2%−1,063−6.1%ReducedHolders
Q2 202217,287$4.87M2.2%−375−2.1%ReducedHolders
Q1 202217,662$4.61M1.7%+16+0.1%AddedHolders
Q4 202117,646$3.88M1.2%+634+3.7%AddedHolders
Q3 202117,012$3.09M1.2%+134+0.8%AddedHolders
Q2 202116,878$3.40M1.3%+105+0.6%AddedHolders
Q1 202116,773$3.60M1.5%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.